FDA Still Not Happy With CBD Industry: Tighter Controls in 2023
The U.S. Food & Drug Administration (FDA) plans to issue new regulatory recommendations for the CBD industry due to prevailing consumer safety concerns. In a statement provide
The U.S. Food & Drug Administration (FDA) plans to issue new regulatory recommendations for the CBD industry due to prevailing consumer safety concerns. In a statement provide